Literature DB >> 8014645

Suboptimal (thin) distal cement mantle thickness as a contributory factor in total hip arthroplasty femoral component failure. A retrospective radiographic analysis favoring distal stem centralization.

M J Star1, C W Colwell, G J Kelman, R T Ballock, R H Walker.   

Abstract

One hundred cemented total hip arthroplasties (THAs) were evaluated regarding the potential benefit of THA femoral component distal stem centralization, specifically regarding cement mantle thickness. Factors potentially predictive of femoral component mechanical loosening, both relating (22 factors) and not relating (41 factors) to cement, were analyzed on initial postoperative radiographs. Nine THAs with femoral component mechanical failure (group 1) were compared to (1) 88 non-failed THAs (group 2) and (2) 9 matched-paired, nonfailed THAs (group 3). Significant differences were evident regarding minimum and maximum cement mantle thickness in Gruen zone 5 and combined zones 5/6 (groups 1 vs 2 and groups 1 vs 3), with failed femoral components having thinner cement mantles. Discriminate analysis determined minimum cement mantle thickness in zone 5 to be the factor most predictive of femoral component failure. These data indicate that a suboptimal (thin) cement mantle at the medial diaphysis (Gruen zones 5 and 6) contributed to femoral component mechanical loosening in this THA series. This relationship may not pertain to femoral stems of different materials or cross-sectional characteristics. Many THA systems currently provide for a method of centralization of the femoral component distal stem as a mechanism to ensure an adequate circumferential distal cement mantle. Continued investigation into techniques directed toward centralization of the distal femoral stem is warranted by the findings of this study.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014645     DOI: 10.1016/0883-5403(94)90063-9

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  8 in total

1.  Prediction of Charnley femoral stem aseptic loosening by early post-operative radiological features.

Authors:  M H A Malik; N Fisher; J Gray; B M Wroblewski; P R Kay
Journal:  Int Orthop       Date:  2005-08-05       Impact factor: 3.075

2.  Results of hip resurfacing.

Authors:  Francesco Falez; Fabio Favetti; Filippo Casella; Matteo Papalia; Gabriele Panegrossi
Journal:  Int Orthop       Date:  2011-01-14       Impact factor: 3.075

3.  Survivorship of the C-Stem total hip replacement using the "French Paradox" technique.

Authors:  Anna S Walsh; Muni Pinjala; Siddharth Lokanathan; Saqif Hossain
Journal:  J Orthop       Date:  2022-02-04

4.  Comparison of distal and proximal centralising devices in hip arthroplasty.

Authors:  N Aydin; M Bezer; A H Akgulle; B Saygi; B Kocaoğlu; O Guven
Journal:  Int Orthop       Date:  2008-08-19       Impact factor: 3.075

5.  Radiographic grading of femoral stem cementation in hip arthroplasty.

Authors:  Flávio Luís Garcia; Arthur Tomotaka Sugo; Celso Hermínio Ferraz Picado
Journal:  Acta Ortop Bras       Date:  2013-01       Impact factor: 0.513

6.  Influence of bone density on morphologic cement penetration in minimally invasive tibial unicompartmental knee arthroplasty: an in vitro cadaver study.

Authors:  Christian B Scheele; Matthias F Pietschmann; Christian Schröder; Igor Lazic; Thomas M Grupp; Peter E Müller
Journal:  J Orthop Surg Res       Date:  2019-10-22       Impact factor: 2.359

7.  Finite element analysis of the effect of cementing concepts on implant stability and cement fatigue failure.

Authors:  Dennis Janssen; Jantien van Aken; Thierry Scheerlinck; Nico Verdonschot
Journal:  Acta Orthop       Date:  2009-06       Impact factor: 3.717

8.  A 2-year prospective clinical and bone density evaluation, with a subset undergoing radiostereometric analysis, using the Absolut cemented stem.

Authors:  Jay R Ebert; Nils O Nivbrant; Victoria Petrov; Piers Yates; David J Wood
Journal:  ANZ J Surg       Date:  2022-02-02       Impact factor: 2.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.